ContactLinkedIn

Symetis

Symetis2023-11-13T09:28:53+00:00
Symetis

CEO
Jacques Essinger

Sector
Medical Devices

Location
Ecublens, Switzerland

Stage
Growth

Status
Exit

Year of Engagement
2016

Endeavour Vision Deal Team
Damien Tappy
Dominik Ellenrieder

Back to all companies

Symetis

Symetis specialises in the development, manufacturing and marketing of next-generation percutaneous heart valve replacement solutions for the treatment of severe cardiac valve conditions.

Symetis was acquired by Boston Scientific in 2017.

Read More

Our Mission

‘To improve the standard of care for millions of people and streamline healthcare delivery by supporting transformative healthcare technologies’

Contact

Endeavour Vision Ltd.
Rue de la Confédération 7,
1204, Geneva
Switzerland

+41 22 544 6000

Click here to get in touch

Quick Links

About
Team
Portfolio
ESG & Impact
News
Contact

Newsletter

Sign up to receive our latest news
Sign Up
We use cookies to improve your experience. By using this site, you are accepting our privacy and cookie policy. OK
Go to Top